Connect with us

Hi, what are you looking for?

Monday, Apr 15, 2024
Mugglehead Magazine
Alternative investment news based in Vancouver, B.C.

International

European Psychiatric Association aligns with PAREA: a multi-organization psychedelic partnership

The new member organization consists of over 78,000 psychiatrists

European Psychiatric Association aligns with PAREA: a multi-organization psychedelic partnership
Photo via European Psychiatric Association.

The Psychedelic Access and Research European Alliance (PAREA) has acquired a very prominent new affiliate organization in the field of mental health.

On Thursday, PAREA announced that the European Psychiatric Association (EPA) was now a full-fledged member of the organization.

The EPA is the primary association representing psychiatry in Europe and has over 78,000 members.

Read more: PAREA: A new psychedelic-focused alliance of prominent companies with common goals

Read more: Vancouver mushroom dispensaries continue to operate in legal grey area

PAREA describes itself as a multidisciplinary civil society partnership comprised of 15 member organizations including Heroic Hearts Project – U.K., MAPS Public Benefit Corporation, Awakn Life Sciences Corp  (NEO: AWKN) (OTCQB: AWKNF), the European Brain Council and many others.

The organization formally launched on June 23 this year and it is essentially concerned with helping to pave the way for psychedelic-assisted therapies (PAT) to be integrated into mainstream healthcare in Europe.

“Building on several decades of research which accelerated in the last few years, psychedelic-assisted therapies offer a very real promise of becoming efficacious, rapidly acting, durable, toxicologically safe treatments for many brain disorders, including mental health conditions such as depression, PTSD, and anxiety. Indeed, 84 million Europeans struggle with mental health disorders and in a few years’ time millions of them might be eligible for a prescription of PAT,” said PAREA representatives.

PAREA also stated that training psychedelic therapists and developing training curricula for healthcare professionals will be essential in the process of beginning to work with patients who are in an altered state of consciousness.

The organization says professional associations like the EPA and independent certification boards will be needed at the beginning of this process to help address a vast range of concerns and requirements related to the knowledge needed for proficiently delivering psychedelic therapies.

“The oversight and active involvement of the European Psychiatric Association will be indispensable in advancing these major tasks and in building a significant medical oversight over PATs in Europe,” added PAREA.

 

Follow Mugglehead on Twitter

Like Mugglehead on Facebook

 

 

 

 

 

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Cannabis

Carrying up to 25 grams is now perfectly legal and cannabis clubs will start small-scale distribution in July

AI and Autonomy

The Artificial Intelligence Act will start to come into force in mid-2024; its approval received praise from IBM, Salesforce and others

Cannabis

The Atlantic Canada cultivator proudly uses the waste of koi carp fish as a fertilizer for its medical cannabis

Lithium

German officials who met with the Argentinian delegation will be travelling to South America next month to further strengthen ties